| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/20/2008 | EP1888508A2 Novel haloalkoxy-substituted salicylic anilides |
| 02/20/2008 | EP1888507A1 Tigecycline and methods of preparation |
| 02/20/2008 | EP1888505A1 Organic compounds |
| 02/20/2008 | EP1888174A1 Use of chalcones for the treatment of viral disorders |
| 02/20/2008 | EP1888173A2 Novel use of (-)-epigallocatechin gallate |
| 02/20/2008 | EP1888116A2 Use of fumagillin and the derivatives thereof to increase the bioavailability of the macrocyclic lactones |
| 02/20/2008 | EP1888102A2 Modulation of peripheral clocks in adipose tissue |
| 02/20/2008 | EP1888091A2 Use of the irritating principal oleocanthal in olive oil, as well as structurally and functionally similar compounds |
| 02/20/2008 | EP1888084A1 Pharmaceutical composition for the inhibition of lipogenesis comprising a regulator of prp19 expression |
| 02/20/2008 | EP1888083A2 Compositions and their uses directed to lmw-ptpase |
| 02/20/2008 | EP1888081A2 Compositions containing pufa and methods of use thereof |
| 02/20/2008 | EP1888080A1 Pharmaceutical compositions of a neuroactive steroid and usees thereof |
| 02/20/2008 | EP1888079A2 Use of polyamines with antibiotics |
| 02/20/2008 | EP1888078A2 Sulphone derivatives for treatment of cancer |
| 02/20/2008 | EP1888077A2 Pharmaceutical composition containing gestagens and/or estrogens and 5-methyl-(6s)-tetrahydrofolate |
| 02/20/2008 | EP1888076A1 Use of pyrazolopyrimidine against cardiovascular diseases |
| 02/20/2008 | EP1888075A1 Therapeutic combination in case of benign prostate hyperplasia |
| 02/20/2008 | EP1888074A1 Agent for the prevention and treatment of liver diseases containing pyrazolopyrimidine derivative |
| 02/20/2008 | EP1888073A1 Immediate-release and high-drug-load pharmaceutical formulations of micronised (4-chlorophenyl)[4-(4-pyridylmethyl)phthalazin-1-yl]and salts thereof |
| 02/20/2008 | EP1888072A1 Immediate-release and high-drug-load pharmaceutical formulations of non-micronised (4-chlorophenyl)[4-(4-pyridylmethyl)phthalazin-1-yl]and salts thereof |
| 02/20/2008 | EP1888071A1 Method for the treatment of drug-induced sexual dysfunction |
| 02/20/2008 | EP1888070A1 Method for the treatment of sexual dysfunctions due to medical conditions |
| 02/20/2008 | EP1888069A2 New antiproliferative drug |
| 02/20/2008 | EP1888067A1 Combination therapy comprising a diaryl urea compound and a pi3, akt kinase or mtor inhibitors (rapamycins) for cancer treatment |
| 02/20/2008 | EP1888066A2 Aminocyclohexanes as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 02/20/2008 | EP1888065A2 Combination therapy comprising diaryl ureas for treating diseases |
| 02/20/2008 | EP1888064A1 Benztropinamine analogs as dopamine uptake inhibitors |
| 02/20/2008 | EP1888063A1 Antifungal agents |
| 02/20/2008 | EP1888062A1 The use of rapamycin derivatives for the treatment and/or prevention of cardiovascular disorders |
| 02/20/2008 | EP1888061A1 Nutrient composition for treating sarcoma and prostate cancer |
| 02/20/2008 | EP1888060A2 Nk-b inhibitors for the treatment of muscular dystrophy |
| 02/20/2008 | EP1888059A2 Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomakers |
| 02/20/2008 | EP1888058A2 Inhibitors of soluble adenylate cyclase |
| 02/20/2008 | EP1888057A2 Hypoallergenic flavor compositions and methods of managing allergic reactions in pets |
| 02/20/2008 | EP1888056A2 Use of ladostigil for the treatment of multiple sclerosis |
| 02/20/2008 | EP1888055A2 Fish oil in stabilized form |
| 02/20/2008 | EP1888054A2 Antimicrobial composition |
| 02/20/2008 | EP1888053A2 Conjugated aromatic compounds for diagnosis and therapy |
| 02/20/2008 | EP1888052A2 Blockade of pin1 prevents cytokine production by activated immune cells |
| 02/20/2008 | EP1888051A2 Sulphonamido-substituted cyclohexyl sulphones for treatment of cancer |
| 02/20/2008 | EP1888050A2 Cyclohexyl sulphones for treatment of cancer |
| 02/20/2008 | EP1888049A2 Localized delivery of cardiac inotropic agents |
| 02/20/2008 | EP1888047A2 Oral ribavirin pharmaceutical compositions |
| 02/20/2008 | EP1888040A2 Pharmaceutical compositions comprising imatinib and a release retardant |
| 02/20/2008 | EP1888038A2 Modified release famciclovir pharmaceutical compositions |
| 02/20/2008 | EP1888037A2 Nanoparticulate clopidogrel formulations |
| 02/20/2008 | EP1888033A2 Method and composition for treating inflammatory disorders |
| 02/20/2008 | EP1888030A1 Pediatric formulation of topiramate |
| 02/20/2008 | EP1888028A1 Pharmaceutical dosage form effective at microcirculatory level containing at least one flavanoid |
| 02/20/2008 | EP1888027A1 Medicated product for local use based on natural materials |
| 02/20/2008 | EP1888026A2 A stable liquid formulation comprising desoximetasone and isopropyl myristate with reduced oxidized impurity during long-term storage |
| 02/20/2008 | EP1888025A2 Medicament carrier composition and method of forming a film therefrom |
| 02/20/2008 | EP1888000A2 Method to predict and prevent oxygen-induced inflammatory tissue injury |
| 02/20/2008 | EP1887891A1 Dietary fiber composition comprising glucomannan, xanthan gum, and alginate |
| 02/20/2008 | EP1740569B1 Imidazole derivatives used as tafia inhibitors |
| 02/20/2008 | EP1722771A4 Compositions and methods for preventing or treating an inflammatory response |
| 02/20/2008 | EP1697304B1 Peroxisome proliferator activated receptor modulators |
| 02/20/2008 | EP1694299B1 Method for drug loading in liposomes |
| 02/20/2008 | EP1675832B1 Heterocyclyl compounds |
| 02/20/2008 | EP1672988A4 Weight-loss supplement |
| 02/20/2008 | EP1651217B1 Alkaline salts of proton pump inhibitors |
| 02/20/2008 | EP1622620B1 Quinazoline derivatives and their use in the treatment of cancer |
| 02/20/2008 | EP1620423B1 Process for the preparation of (4-hydroxy-6-oxo-tetrahydropyran-2-yl) acetonitrile and derivatives thereof |
| 02/20/2008 | EP1613312B1 Benzimidazole derivatives and their use for modulating the gaba a receptor complex |
| 02/20/2008 | EP1603895B1 Substituted benzoylureidopyridyl-piperidine and -pyrrolidine carboxylic acid derivatives, method for the production thereof and the use thereof |
| 02/20/2008 | EP1603559B1 Pharmaceutical composition for intracellular acidification with cis-urocanic acid |
| 02/20/2008 | EP1581522B1 Flavaxate derivatives as muscarinic receptor antagonists |
| 02/20/2008 | EP1581226B1 Inclusion complex of anti-tubercular rifampicin with beta-cyclodextrin or 2-hydroxypropyl beta-cyclodextrin and a process for producing the same |
| 02/20/2008 | EP1578294A4 Methods and systems for enabling and stabilizing tooth movement |
| 02/20/2008 | EP1575600B1 Cosmetic preparations of polyhexamethylenebiguanidine hydrochloride and distearyldimethylammonium chloride |
| 02/20/2008 | EP1572211B1 Therapeutic applications of 2-substituted 4-heteroarylpyrimidines |
| 02/20/2008 | EP1562449A4 Composition for enhancing physical performance |
| 02/20/2008 | EP1560829B1 Pyrimido compounds having antiproliferative activity (ii) |
| 02/20/2008 | EP1558247B1 Benzimidazole derivatives |
| 02/20/2008 | EP1556384B1 Pyrimido compounds having antiproliferative activity |
| 02/20/2008 | EP1556381B1 Pyrazole amides for treating hiv infections |
| 02/20/2008 | EP1555022B1 Sustained release formulation of acetaminophen and tramadol |
| 02/20/2008 | EP1545506B1 Use of angelicin and of its structural analogues for the treatment of thalassemia |
| 02/20/2008 | EP1539108B1 Vesicle-encapsulated corticosteroids for the treatment of cancer |
| 02/20/2008 | EP1521581B1 Diarylmethylpiperazines as prophylactic or therapeutic agents for viral myocarditis |
| 02/20/2008 | EP1515729B1 Quaternised ammonium cyclodextrin compounds |
| 02/20/2008 | EP1496908B1 Combination of glivec(sti571) with a cyclin-dependent kinase inhibitor, especially flavopiridol in the treatment of cancer |
| 02/20/2008 | EP1458389B1 Aqueous solutions of moxaverin for the treatment of erectile dysfunction |
| 02/20/2008 | EP1448561B1 Beta 3 adrenergic agonists |
| 02/20/2008 | EP1443964B1 Photodynamic therapy for the treatment of hair loss |
| 02/20/2008 | EP1436271B1 Phenyl-piperazine derivatives as serotonin reuptake inhibitors |
| 02/20/2008 | EP1432417B1 Substituted benzimidazole compounds and their use for the treatment of cancer |
| 02/20/2008 | EP1427417B1 3-substituted 6,7-dihydroxytetrahydroisoquinoline derivatives for use as antibacterial agents |
| 02/20/2008 | EP1427392B1 New self emulsifying drug delivery system |
| 02/20/2008 | EP1424907B1 Oil composition |
| 02/20/2008 | EP1421092A4 Neutral glycosphingolipids and glycosyl-sphingosines and methods for isolating the same |
| 02/20/2008 | EP1421091A4 Saccharide sulfation methods |
| 02/20/2008 | EP1414828B9 Antitumoral analogs |
| 02/20/2008 | EP1408966B1 Synergistic pharmaceutical combinations for the prevention or treatment of diabetes |
| 02/20/2008 | EP1406667B1 Methods for increasing in vivo efficacy of oligonucleotides and inhibiting inflammation in mammals |
| 02/20/2008 | EP1404704B9 Bridged bicyclic serine protease inhibitors |
| 02/20/2008 | EP1383747B1 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf) |
| 02/20/2008 | EP1372637B1 Premixed amiodarone parenteral solution and method for making the same |
| 02/20/2008 | EP1359881B1 Container with low oxygen content containing ff-mas |
| 02/20/2008 | EP1354871B1 Biphenyl derivatives |